Skip to main content
. 2024 Feb 15;15(2):209–219. doi: 10.4239/wjd.v15.i2.209

Table 4.

Comparison of blood glucose index and blood lipid index pre-treatment, 3 months after treatment, and 6 months after treatment in 3 groups

Group LDL-C (pmol/L)
FBG(pmol/L)
HbA1c(%)
Pre-treatment
After 3 months of treatment
After 6 months of treatment
Pre-treatment
After 3 months of treatment
After 6 months of treatment
Pre-treatment
After 3 months of treatment
After 6 months of treatment
Control group (n = 50) 1.31 ± 0.43 1.43 ± 0.44 1.48 ± 0.45 13.52 ± 3.35 13.46 ± 3.33 13.37 ± 3.28 9.16 ± 1.55 8.90 ± 1.35 7.65 ± 1.26
Test group A (n = 50) 1.34 ± 0.43 1.76 ± 0.46a 2.18 ± 0.50a 13.69 ± 3.76 12.34 ± 3.82a 12.98 ± 2.98a 8.98 ± 1.58 8.55 ± 1.30 7.09 ± 1.15a,b
Test group B (n = 50) 1.33 ± 0.40 1.87 ± 0.48a 2.41 ± 0.58a,b 13.60 ± 3.80 9.64 ± 1.45a 7.30 ± 1.48a,b 9.35 ± 1.52 8.20 ± 1.2a 6.45 ± 1.10a,b
F value 0.067 11.717 44.330 0.031 20.859 49.495 0.712 3.603 13.130
P value 0.935 < 0.001 < 0.001 0.970 < 0.001 < 0.001 0.492 0.030 < 0.001
a

P < 0.05 vs group pre-treatment.

b

P < 0.05 vs 3 months after treatment.

LDL-C: Low-density lipoprotein cholesterol; FBG: Fasting blood glucose; HbA1c: Hemoglobin A1c.